Showing results (171-180 of 250) with videos related to

Sort By:
Pageof 25
Haematologica|September 12, 2000
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosineP L Zinzani, M Magagnoli, M Bendandi, et al.
Leukemia & Lymphoma|August 1, 1994
Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR)E Pasquini, M Nicolini, G Rosti, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 1, 1989
Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the Ki-67 monoclonal antibodyB Falini, L Flenghi, M Fagioli, et al.
Histopathology|December 1, 1987
Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodiesB Falini, H Stein, S Pileri, et al.
British Journal of Haematology|March 1, 1994
Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 casesS Pileri, M Bocchia, C D Baroni, et al.
British Journal of Haematology|April 1, 1995
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimensB Falini, S Venturi, M Martélli, et al.
British Journal of Haematology|July 1, 1988
Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodiesB Falini, S Canino, S Sacchi, et al.
Leukemia & Lymphoma|January 1, 1994
Retreatment with 2-CdA of progressed HCL patientsF Lauria, D Benfenati, D Raspadori, et al.
European Journal of Gynaecological Oncology|June 28, 2006
Double laparotomy wound recurrence of endometrial carcinomaG C Balbi, A Cardone, A Monteverde, et al.
Leukemia & Lymphoma|December 1, 1995
Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferationA Monteverde, E Sabattini, S Poggi, et al.
Pageof 25